Cost-Effectiveness of the MiniMed 780G System for Type 1 Diabetes
Cost-Effectiveness of the MiniMed 780G System for Type 1 Diabetes
About this item
Full title
Author / Creator
Publisher
United States: Intellisphere, LLC
Journal title
Language
English
Formats
Publication information
Publisher
United States: Intellisphere, LLC
Subjects
More information
Scope and Contents
Contents
Advances in diabetes technology have led to improved glycemic control. However, no study has evaluated the economic impact of advanced hybrid closed-loop (AHCL) technology in the US compared with older and less expensive treatments. We assessed the cost-effectiveness of the MiniMed 780G system (MM780G) with AHCL technology vs multiple daily injecti...
Alternative Titles
Full title
Cost-Effectiveness of the MiniMed 780G System for Type 1 Diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3189922298
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3189922298
Other Identifiers
ISSN
1088-0224,1936-2692
E-ISSN
1936-2692
DOI
10.37765/ajmc.2025.89722
